Who owns YS BIOPHARMA CO LTD?

Tip: Access positions for across all investors

Analyze quarterly positions in Ys Biopharma with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Ys Biopharma stock

Who bought or sold YS BIOPHARMA CO LTD this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
LMR Partners 1.1M $84k 0% Dec 2024
 View chart
Valliance Asset Management 750k $50k 0% Sep 2024
 View chart
BFAM Partners 550k $44M 0% Sep 2024
 View chart
Jane Street 498k $40k 0% Dec 2024
 View chart
Finepoint Capital 490k $49k 0% Dec 2024
 View chart
Millennium Management 425k $34k 100% Dec 2024
 View chart
Bracebridge Capital 232k $18k 0% Dec 2024
 View chart
Ovata Capital Management 150k $15k 0% Dec 2024
 View chart
Calamos Advisors 146k $15k 0% Dec 2024
 View chart
Q Global Advisors 131k $10k 0% Dec 2024
 View chart
Athos Capital 129k $45k 0% Dec 2024
 View chart
Whitebox Advisors 125k $9.9k 0% Dec 2024
 View chart
D. E. Shaw & Co 100k $9.9k 0% Dec 2024
 View chart
Saba Capital Management 97k $7.7k 0% Dec 2024
 View chart
Walleye Trading Advisors 95k $7.5k -5% Dec 2024
 View chart
Cantor Fitzgerald, L. P. 77k $5.1k 0% Sep 2024
 View chart
Deutsche Bank Aktiengesellschaft 75k $6.0k 0% Dec 2024
 View chart
Clear Street 48k $3.0k -3% Sep 2024
 View chart
Meteora Capital 25k $1.7k 0% Sep 2024
 View chart
SkyView Investment Advisors 12k $999.999000 0% Sep 2024
 View chart
Ancora Advisors 5.1k $400.970000 0% Dec 2024
 View chart
HGC Investment Management 5.0k $397.000000 0% Dec 2024
 View chart

Who sold out of Ys Biopharma?

Fund or Company Name Date Sold Shares Held Valued At
Highbridge Capital Management Sep 2024 266k $13k
Cowen And Company Sep 2024 213k $14k
Two Sigma Securities Sep 2024 17k $1.2k